Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. inflammation promoting
Show results for
Products
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Inflammation Promoting Articles & Analysis

11 news found

BRIM Biotech submits US Phase 3 clinical trial protocol for BRM421 in the treatment of dry eye disease to the FDA

BRIM Biotech submits US Phase 3 clinical trial protocol for BRM421 in the treatment of dry eye disease to the FDA

It stimulates stem cell differentiation, repairs the cornea, inhibits inflammation, and promotes recovery in DED. Phase 2 clinical trial results have shown that BRM421 not only significantly improved DED symptoms including dryness, burning/stinging, and photophobia within one week of treatment, but also showed efficacy in repairing the cornea in 15 days. ...

ByBRIM Biotechnology, Inc.


SANUWAVE Business Update

SANUWAVE Business Update

UltraMIST®, a technology that promotes healing by controlling inflammation and reducing bacteria, will be sold in the Aesthetics market, initially launching in MedSpas as a post-facial treatment. ...

BySanuwave and Sanuwave Health, Inc.


Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation

Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation

The STEADFAST Phase 1/2 study is an important milestone for genomic medicine that we anticipate will yield insights regarding CAR-Treg biology and could potentially help patients living with a donated HLA-A2 mismatched kidney from a living donor by promoting immunological tolerance to the graft.” “This is an exciting time for the renal transplant community and more ...

BySangamo Therapeutics


Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease

Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease

Aldosterone-mediated activation of mineralocorticoid receptors (MR) in the kidney drive the downward spiral by promoting tissue inflammation and injury. Finerenone is an investigational, non-steroidal, selective MR antagonist that in preclinical studies has been shown to block harmful effects of MR overactivation, which is thought to contribute to CKD progression ...

ByBayer AG


Neuropathix, Inc. Forms Dermique Incorporated its New Wholly Owned Subsidiary for the Ownership and Commercialization of the Company’s Over-The-Counter Cosmeceutical Assets

Neuropathix, Inc. Forms Dermique Incorporated its New Wholly Owned Subsidiary for the Ownership and Commercialization of the Company’s Over-The-Counter Cosmeceutical Assets

Our preclinical studies have demonstrated, alongside certain isolated test subjects, that LEA™ is simply better than CBD for targeting inflammation, itch, and burn,” said Dean Petkanas, CEO of Neuropathix. ...

ByNeuropathix, Inc.


Neuropathix, Inc. Announces Publication of PCT Patent Application for the Treatment of Radiation Dermatitis and Other Skin Disorders

Neuropathix, Inc. Announces Publication of PCT Patent Application for the Treatment of Radiation Dermatitis and Other Skin Disorders

IL-6 is a cytokine (an immune system signaling molecule) that has been shown to promote inflammation and is currently among the targets believed to be creating the cytokine storm in SARS-CoV-2 (“COVID-19”). ...

ByNeuropathix, Inc.


NNI Will Hold Webinar on Implantable Nanosensors on November 4, 2020

NNI Will Hold Webinar on Implantable Nanosensors on November 4, 2020

NNI states that while there have been significant advances in developing implantable sensors for monitoring and responding to tissue growth, infection, and inflammation surrounding implants, as well as communicating such responses to hand held devices for real-time responses, obstacles include the use of non-toxic sensor chemistries, information storage, healthcare privacy, and ...

ByBergeson & Campbell, P.C.


Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine

Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine

IL-6 is a cytokine (an immune system signaling molecule) that has been shown to promote inflammation and currently among the targets believed to be creating the cytokine storm in SARS-CoA-2 (“COVID-19”). ...

ByNeuropathix, Inc.


tiakis (formerly Proteo Biotech AG) Elafin Enters the Clinic For Subcutaneous Use In Pulmonary Arterial Hypertension

tiakis (formerly Proteo Biotech AG) Elafin Enters the Clinic For Subcutaneous Use In Pulmonary Arterial Hypertension

Elafin is identical to the human protein elafin with high specificity for tissue destroying and inflammation promoting proteases. The development program of Elafin is focused on the late stage development of Elafin in major surgery and early stage development in pulmonary arterial hypertension (PAH). ...

Bytiakis BIOTECH AG


tiakis receives GLP Certificate from Competent Authority

tiakis receives GLP Certificate from Competent Authority

Elafin is identical to the human protein elafin with high specificity for tissue destroying and inflammation promoting proteases. The development program of Elafin is focused on the late stage development of Elafin in major surgery and early stage development in pulmonary arterial hypertension (PAH). ...

Bytiakis BIOTECH AG


Diesel Exhaust + Cholesterol = Cardiovascular Disease

Diesel Exhaust + Cholesterol = Cardiovascular Disease

Published in today's edition of the online journal 'Genome Biology,' the study is the first to explain how fine particles in air pollution work with artery-clogging fats to switch on the genes that cause blood vessel inflammation and lead to hardening of the arteries and cardiovascular disease. ...

ByEnvironment News Service (ENS)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT